Greg Sobolski, a partner in the Intellectual Property Litigation Practice, represents patentees and accused infringers in the federal district courts, the International Trade Commission, arbitrations, and in appeals before the Federal Circuit.
Mr. Sobolski represents clients at all stages of patent litigation, with a focus on trial and appeal. With complementary experience in the law and the biological sciences, Mr. Sobolski regularly litigates a range of complex technologies that span various industries, including:
Automotive
Biometrics
Biotechnology
Medical devices
Nanotechnology
Oil services
Pharmaceuticals
Solar energy
Telecommunications
He served as a law clerk to Judge Kimberly Moore of the United States Court of Appeals for the Federal Circuit. He also held a fellowship at the National Institutes of Health, and has published in the Journal of the American Medical Association, Cambridge Quarterly, and Annals of Internal Medicine.
Experience
Mr. Sobolski’s representative matters include:
Life Sciences
Pharmacyclics v. AstraZeneca – Representing Pharmacyclics in an infringement action and countersuit related to blood cancer drugs
AbbVie v. Novartis Vaccines and Diagnostics – Representing AbbVie in a dispute involving patents related to the Hepatitis C Virus
Depomed v. Roxane Laboratories – Defended Roxane at trial and on appeal in a Hatch-Waxman case related to tapentadol hydrochloride
AbbVie v. Gilead Sciences – Represented AbbVie in an infringement action related to treatment for Hepatitis C infection
Par Pharmaceutical v. TWi Pharmaceuticals – Represented Par in an appeal related to megestrol acetate
Mayo Labs. v. Prometheus Labs – Represented Mayo in landmark Federal Circuit and Supreme Court appeals regarding patent-eligible subject matter
Purdue Pharma v. Actavis Elizabeth – Defended Actavis in Hatch-Waxman case related to analgesic extended release tablets. Following trial, the matter settled pursuant to an agreement that was publicly announced as generating more than US$100 million in combined gross profit
Additional Technologies
Nanosys v. QD Vision – Represented Nanosys in an infringement action related to quantum dot nanotechnology
DuPont v. Heraeus Materials Technology – Defended Heraeus in multi-jurisdictional competitor cases related to silver photovoltaic pastes used in solar panel manufacturing
Cross Match Technologies v. Suprema and Mentalix – Represented Cross Match in a case before the International Trade Commission related to proprietary biometric identification technologies (fingerprint scanners). Following trial, the ITC issued an exclusion order barring the accused products from importation into the US. Following appeal, the Federal Circuit issued an en banc affirmance
Two Latham teams were recognized for securing a rare DOJ declination on behalf of Lifecore Biomedical Inc. and a Patent Trial and Appeals Board win for CoStar Realty Information Inc. and Duolingo Inc.
Latham honored for securing a US$10.75 million damages verdict for client Philip Morris International in a patent infringement trial over vaping technology against R.J. Reynolds Vapor.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.